Fort Collins, CO 80535, US
Medical Devices & Equipment
Our electronic technology platform is bound to revolutionize women’s healthcare with diagnostic tools for women and their doctors & payers. To mitigate startup investment risk, the first app is an already FDA-cleared electronic fertility monitor for women at home, with data sharing for the healthcare providers (menstrual vital sign signatures). It’s an affordable, simple-to-use means of self-monitoring the menstrual cycle, around which revolves much in women’s health and lifestyle.
bioZhena’s technology provides for non-interventional reproductive management, aiding conception and natural birth control without hormones, and automatically detecting pregnancy – planned or accidental.
We will offer early warning of cervical cancer and other STDs as a built-in screen performed innocuously in the privacy of one’s home, avoiding the problems of the Pap smear test (high cost, reliability issues causing anxiety, uncomfortable, missed by many women). The same hardware used in pregnancy will improve management of birthing, incl. prematurity – a major benefit for public health. Only software will change, a significant profitability factor along with the SaaS implementation.
To start, the market of trying-to-conceive women will benefit from the unprecedented ability to indicate in plain English the fertile window as FERTILE DAY 1, 2, and 3 = OVULATION. Get that! Another indication: CONCEPTION! as the Ovulona™ will automatically detect pregnancy much earlier and more reliably than any existing home pregnancy test – and it will also automatically assess the delivery date.
Ovulona™ tracks the cyclic mechanism via the end-organ effect of the brain-ovary feedback loop on the uterine cervix. Numerous benefits ensue in addition to noninvasive sex management – such as aiding baby gender pre-selection, better management of menstrual cramps, PMS and peri-menopause.
Do review https://lnkd.in/bihVaAi and the News/Links